66. 在肝癌的 systemic therapy 中,下列何者是屬於 immune checkpoint inhibitor 類治療藥物?
(1) Cabozantinib
(2) Durvalumab
(3) Bevacizumab
(4) Tremelimumab
(5) Atezolizumab
(A) (1)+(2)+(3)
(B) (2)+(3)+(4)
(C) (1)+(3)+(5)
(D) (2)+(4)+(5)
(E) (3)+(4)+(5)
詳解 (共 1 筆)
未解鎖
1. 題目解析 題目要求選出屬於免疫檢查...